Abridge, the leader in generative AI for clinical documentation, recently announced a significant $150M investment through a Series C funding. This investment marks one of the largest funding rounds ever made for generative AI for health care.
Abridge plans to use this funding to support improvements to existing product lines and continue to develop new ways to personalize notes, integrate more deeply into electronic medical record (EMR) systems, and provide clinicians with after-visit insights.
UPMC Enterprises continues to support Abridge as part of our portfolio, showcasing our commitment to next-generation health care and innovation through technology.
Read the Abridge press release and their featured articles to learn more:
- Abridge Raises $150 Million To Make AI Medical Scribes Even Smarter | Forbes
- Abridge raises $150m as clinical notes automation market heats up | STAT News
- Lightspeed, CVS back Abridge’s $150M round for generative AI | Fierce Healthcare
- VCs Are Betting Big on “Screaming Hot” AI Medical Scribe Startups | Business Insider
- ‘We’ve met the moment’: A Lawrenceville startup using generative AI to help doctors gets funding boost | Pittsburgh Post-Gazette
- Pittsburgh Inno – Abridge gets $150M in Series C funding round | Pittsburgh Business Times
